« Back
Home /
Zonisamide

Zonisamide

Manufacturer	MedChem Express
Category	Food Safety Antibiotics Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	200 mg
Item no.	HY-B0124-200mg
Targets	Carbonic Anhydrase; Calcium Channel; Sodium Channel
CASRN	68291-97-4
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy[1][2][3][4].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neurodegeneration
MolecularWeight	212.23
Clinical_Information	Launched
Manufacturers Research_Area	Neurological Disease
Solubility	DMSO : 250 mg/mL (ultrasonic)\|H2O : 0.67 mg/mL (ultrasonic)
Manufacturers Target	Apoptosis; Carbonic Anhydrase
Isoform	CA Ⅱ
Pathway	Apoptosis; Metabolic Enzyme/Protease
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0124-200mg-safety-datasheet.pdf